About InnoGenomics
InnoGenomics is a company based in New Orleans (United States) founded in 2010. InnoGenomics offers products and services including InnoTyper® 21, InnoQuant® HY, SpermX™, Mock Forensic Samples, and Custom Services. InnoGenomics operates in a competitive market with competitors including DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
- Headquarter New Orleans, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Innogenomics Technologies, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$350.64 K (USD), Grant
Jan 01, 2018
-
Investors
Ojp
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InnoGenomics
InnoGenomics offers a comprehensive portfolio of products and services, including InnoTyper® 21, InnoQuant® HY, SpermX™, Mock Forensic Samples, and Custom Services.
System for forensic DNA analysis in challenging samples.
Assesses human and male DNA quantity and quality.
Captures sperm cells for forensic DNA processing.
Simulates forensic scenarios for lab testing.
Provides custom biological samples and analysis.
People of InnoGenomics
Unlock access to complete
Unlock access to complete
Funding Insights of InnoGenomics
Investors in InnoGenomics
InnoGenomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Ojp and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Federal justice system funding, training, and resources are provided.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for InnoGenomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InnoGenomics
Investment portfolio details for InnoGenomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InnoGenomics
Detailed financials for InnoGenomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innogenomics Comparisons
Peer comparison for InnoGenomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InnoGenomics
InnoGenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Molecular assays for disease detection are developed using proprietary technology.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Instruments for rapid human DNA identification are developed.
|
Detailed competitors of InnoGenomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innogenomics
Complete news archive for InnoGenomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InnoGenomics
InnoGenomics was founded in 2010 and raised its 1st funding round 1 year after it was founded.
InnoGenomics is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
InnoGenomics Technologies is a biotechnology company engaged in the development of next-generation genetic markers and test kits. The company has invented a mini-primer design that has allowed usage of Retrotransposable Elements (REs) as informative biomarkers. It has developed RE-based PCR and Real-Time qPCR assays which can be used in various fields including forensic and missing person identification, relationship and ancestral ethno-geographic establishment, and molecular diagnostics. As of September 23, 2016, the company offers 4 products: InnoQuant Kit- for checking quality, integrity and quantification of human DNA; INNOTYPER 21- a small amplicon (60-125 bp) DNA typing system; INNOQUANT HY- test for measuring quality, quantity and integrity of human male DNA and realistic mock samples for simulating forensic situations. The company is also developing a liquid biopsy method based on their InnoQuant kit technology for cancer detection and monitoring. The cancer detection device is supported by the U.S. National Cancer Institute (NCI).
InnoGenomics's top competitors include DermTech, Biocartis and Molbio Diagnostics.
InnoGenomics offers InnoTyper® 21, InnoQuant® HY, SpermX™, Mock Forensic Samples, and Custom Services.
InnoGenomics has 2 investors. Key investors include Ojp, and National Science Foundation.